Unconventional wisdom.
Patients with colon cancer enrolled in CALGB 89803 (aka the trial that set a thousand secondary analyses in motion) who reported drinking daily artificially sweetened beverages like Coke lived longer without disease than their aspartame-free counterparts. | Guercio, PLoS One 2018
Comments
Post a Comment